Header Logo

Connection

Ross Abrams to Humans

Back to Details
This is a "connection" page, showing publications Ross Abrams has written about Humans.
Ross Abrams
Connection Strength
1.244
Humans
  1. Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial. Am J Clin Oncol. 2020 03; 43(3):173-179.
    View in: PubMed
    Score: 0.040
  2. Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity: Improved Efficacy and Reduced Toxicity. Am J Clin Oncol. 2019 01; 42(1):1-5.
    View in: PubMed
    Score: 0.037
  3. Role of chemoradiotherapy in the adjuvant and neoadjuvant settings for resectable pancreatic cancer. Clin Oncol (R Coll Radiol). 2014 Sep; 26(9):551-9.
    View in: PubMed
    Score: 0.027
  4. Radiotherapy for soft tissue sarcoma: 50 years of change and improvement. Am Soc Clin Oncol Educ Book. 2014; 244-51.
    View in: PubMed
    Score: 0.026
  5. Evolving concepts regarding the use of radiotherapy in the adjuvant management of periampullary pancreatic adenocarcinoma. Cancer J. 2012 Nov-Dec; 18(6):624-32.
    View in: PubMed
    Score: 0.024
  6. Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1355-64.
    View in: PubMed
    Score: 0.024
  7. Radiation Therapy Oncology Group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):901-8.
    View in: PubMed
    Score: 0.023
  8. Radiotherapy in the adjuvant management of pancreatic adenocarcinoma: is it helpful? Expert Rev Gastroenterol Hepatol. 2012 Apr; 6(2):149-61.
    View in: PubMed
    Score: 0.023
  9. Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):809-16.
    View in: PubMed
    Score: 0.021
  10. Review and commentary on the role of radiation therapy in the adjuvant management of pancreatic cancer. Am J Clin Oncol. 2010 Feb; 33(1):101-6.
    View in: PubMed
    Score: 0.020
  11. Intracranial metastatic disease spares the limbic circuit: a review of 697 metastatic lesions in 107 patients. Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):504-12.
    View in: PubMed
    Score: 0.020
  12. Application of holographic display in radiotherapy treatment planning II: a multi-institutional study. J Appl Clin Med Phys. 2009 May 28; 10(3):115-124.
    View in: PubMed
    Score: 0.019
  13. Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol. 2009 Jul; 16(7):1751-6.
    View in: PubMed
    Score: 0.019
  14. Evaluation of four volume-based image registration algorithms. Med Dosim. 2009; 34(4):317-22.
    View in: PubMed
    Score: 0.018
  15. Cholangiocarcinoma--what level of evidence should we have? Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):1-2.
    View in: PubMed
    Score: 0.018
  16. Management of a patient with borderline resectable pancreatic cancer. Case report and review. Oncology (Williston Park). 2008 Nov 30; 22(13):1524-9.
    View in: PubMed
    Score: 0.018
  17. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol. 2008 Jul 20; 26(21):3503-10.
    View in: PubMed
    Score: 0.018
  18. A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy. Brachytherapy. 2007 Apr-Jun; 6(2):164-8.
    View in: PubMed
    Score: 0.016
  19. Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg. 2007 Mar; 142(3):285-8.
    View in: PubMed
    Score: 0.016
  20. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys. 2007 May 01; 68(1):178-82.
    View in: PubMed
    Score: 0.016
  21. Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal". Drugs. 2007; 67(17):2481-5; discussion 2491-3.
    View in: PubMed
    Score: 0.016
  22. Adjuvant therapy for pancreatic cancer: current status, future directions. Semin Oncol. 2006 Dec; 33(6 Suppl 11):S10-3.
    View in: PubMed
    Score: 0.016
  23. Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC). Radiother Oncol. 2006 Nov; 81(2):163-7.
    View in: PubMed
    Score: 0.016
  24. Radiotherapy in the adjuvant management of pancreatic adenocarcinoma. Semin Oncol. 2005 Dec; 32(6 Suppl 9):S30-2.
    View in: PubMed
    Score: 0.015
  25. Radiochemotherapy in the management of pancreatic cancer--part II: use in adjuvant and locally unresectable settings. Semin Radiat Oncol. 2005 Oct; 15(4):235-44.
    View in: PubMed
    Score: 0.015
  26. Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003. Surg Oncol Clin N Am. 2004 Oct; 13(4):621-38, ix.
    View in: PubMed
    Score: 0.014
  27. Short report: Plasma based biomarkers detect radiation induced brain injury in cancer patients treated for brain metastasis: A pilot study. PLoS One. 2023; 18(11):e0285646.
    View in: PubMed
    Score: 0.013
  28. Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):166-71.
    View in: PubMed
    Score: 0.013
  29. Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848. Int J Radiat Oncol Biol Phys. 2024 Jan 01; 118(1):107-114.
    View in: PubMed
    Score: 0.013
  30. Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985? Int J Radiat Oncol Biol Phys. 2003; 56(4 Suppl):3-9.
    View in: PubMed
    Score: 0.012
  31. Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB): A Systematic Review and Delphi Consensus Statement. JAMA Oncol. 2022 06 01; 8(6):929-937.
    View in: PubMed
    Score: 0.012
  32. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol. 2002 May 01; 20(9):2267-76.
    View in: PubMed
    Score: 0.012
  33. Initial estimates of continuous positive airway pressure (CPAP) on heart volume, position and motion in patients receiving chest radiation. Med Dosim. 2022 Summer; 47(2):191-196.
    View in: PubMed
    Score: 0.011
  34. Single-Fraction Celiac Plexus Radiosurgery: A Preliminary Proof-of-Concept Phase 2 Clinical Trial. Int J Radiat Oncol Biol Phys. 2022 07 01; 113(3):588-593.
    View in: PubMed
    Score: 0.011
  35. Continuing controversy over adjuvant therapy of pancreatic cancer. Lancet. 2001 Nov 10; 358(9293):1565-6.
    View in: PubMed
    Score: 0.011
  36. Impact of radiation therapy facility volume on survival in patients with cancer. Cancer. 2021 11 01; 127(21):4081-4090.
    View in: PubMed
    Score: 0.011
  37. Adjuvant therapy for pancreatic adenocarcinoma. J Gastrointest Surg. 2001 Jan-Feb; 5(1):6-7.
    View in: PubMed
    Score: 0.011
  38. Impact of Diabetes and Insulin Use on Prognosis in Patients With Resected Pancreatic Cancer: An Ancillary Analysis of NRG Oncology RTOG 9704. Int J Radiat Oncol Biol Phys. 2021 01 01; 109(1):201-211.
    View in: PubMed
    Score: 0.010
  39. Is there a role for radiotherapy in the management of upper gastrointestinal malignancies? Surg Oncol Clin N Am. 2000 Jul; 9(3):525-38, ix.
    View in: PubMed
    Score: 0.010
  40. Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma. Neuro Oncol. 2020 06 09; 22(6):830-837.
    View in: PubMed
    Score: 0.010
  41. Object-based visual attention with endogenous orienting. Percept Psychophys. 2000 May; 62(4):818-33.
    View in: PubMed
    Score: 0.010
  42. Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704. Oncologist. 2020 03; 25(3):e477-e483.
    View in: PubMed
    Score: 0.010
  43. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Int J Radiat Oncol Biol Phys. 1999 Jul 15; 44(5):1039-46.
    View in: PubMed
    Score: 0.010
  44. Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history. Am J Clin Oncol. 1999 Feb; 22(1):22-8.
    View in: PubMed
    Score: 0.009
  45. The Impact of Graduates' Job Preferences on the Current Radiation Oncology Job Market. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):27-32.
    View in: PubMed
    Score: 0.009
  46. Adjuvant therapy for pancreatic cancer: back to the future. Int J Radiat Oncol Biol Phys. 1998 Aug 01; 42(1):59-63.
    View in: PubMed
    Score: 0.009
  47. Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery. J Neurooncol. 2018 Sep; 139(3):689-697.
    View in: PubMed
    Score: 0.009
  48. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center. Cancer J Sci Am. 1998 May-Jun; 4(3):178-84.
    View in: PubMed
    Score: 0.009
  49. Fixation point offsets facilitate endogenous saccades. Percept Psychophys. 1998 Feb; 60(2):201-8.
    View in: PubMed
    Score: 0.009
  50. Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: experience with Cisplatinum-based chemoradiotherapy in 76 patients. Int J Radiat Oncol Biol Phys. 1997 Dec 01; 39(5):1077-85.
    View in: PubMed
    Score: 0.009
  51. Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery. J Neurooncol. 2018 Jan; 136(2):289-298.
    View in: PubMed
    Score: 0.008
  52. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997 Sep; 226(3):248-57; discussion 257-60.
    View in: PubMed
    Score: 0.008
  53. Hodgkin and non-Hodgkin lymphoma: local-regional radiation therapy after bone marrow transplantation. Radiology. 1997 Jun; 203(3):865-70.
    View in: PubMed
    Score: 0.008
  54. Domestic Job Shortage or Job Maldistribution? A?Geographic Analysis of the Current Radiation?Oncology Job Market. Int J Radiat Oncol Biol Phys. 2017 09 01; 99(1):9-15.
    View in: PubMed
    Score: 0.008
  55. Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer. Br J Cancer. 2017 May 09; 116(10):1264-1270.
    View in: PubMed
    Score: 0.008
  56. ACR Appropriateness Criteria? Resectable Pancreatic Cancer. Am J Clin Oncol. 2017 Apr; 40(2):109-117.
    View in: PubMed
    Score: 0.008
  57. Role of radiation therapy in the management of the patient with pancreatic cancer. Oncology (Williston Park). 1996 Sep; 10(9 Suppl):13-7.
    View in: PubMed
    Score: 0.008
  58. Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trial. Radiother Oncol. 2016 08; 120(2):212-6.
    View in: PubMed
    Score: 0.008
  59. ACR Appropriateness Criteria? Borderline and Unresectable Pancreas Cancer. Oncology (Williston Park). 2016 Jul; 30(7):619-24, 627, 632.
    View in: PubMed
    Score: 0.008
  60. Advances in Radiation Therapy for Primary and Metastatic Adult Soft Tissue Sarcomas. Curr Oncol Rep. 2016 06; 18(6):36.
    View in: PubMed
    Score: 0.008
  61. ACR Appropriateness Criteria Radiologic Management of Hepatic Malignancy. J Am Coll Radiol. 2016 Mar; 13(3):265-73.
    View in: PubMed
    Score: 0.008
  62. RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704. Int J Radiat Oncol Biol Phys. 2016 Mar 01; 94(3):554-60.
    View in: PubMed
    Score: 0.007
  63. Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head. Surg Clin North Am. 1995 Oct; 75(5):925-38.
    View in: PubMed
    Score: 0.007
  64. Comparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: Analysis of the pretrial benchmark case for the SCALOP trial. Radiother Oncol. 2015 Dec; 117(3):432-7.
    View in: PubMed
    Score: 0.007
  65. Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2015 Nov 15; 93(4):810-8.
    View in: PubMed
    Score: 0.007
  66. Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas. Clin Cancer Res. 2015 Dec 15; 21(24):5612-8.
    View in: PubMed
    Score: 0.007
  67. Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel. Int J Radiat Oncol Biol Phys. 2015 Jul 01; 92(3):602-12.
    View in: PubMed
    Score: 0.007
  68. Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists. Ann Surg Oncol. 2015 Sep; 22(9):2846-52.
    View in: PubMed
    Score: 0.007
  69. Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):1053-1059.
    View in: PubMed
    Score: 0.007
  70. Color-based inhibition of return. Percept Psychophys. 1995 Apr; 57(3):402-8.
    View in: PubMed
    Score: 0.007
  71. Radiation therapy in the management of patients with malignant carcinoid tumors. Cancer. 1995 Mar 15; 75(6):1386-90.
    View in: PubMed
    Score: 0.007
  72. The clinical use of multimodality therapy in the management of cancer. In Vivo. 1994 Nov-Dec; 8(5):635-42.
    View in: PubMed
    Score: 0.007
  73. Radiosensitizing effect of anti-HER2/neu agents: Report of 2 cases and review of the literature. Pract Radiat Oncol. 2015 Mar-Apr; 5(2):e61-5.
    View in: PubMed
    Score: 0.007
  74. The gap effect and inhibition of return: interactive effects on eye movement latencies. Exp Brain Res. 1994; 98(3):483-7.
    View in: PubMed
    Score: 0.006
  75. Supportive care considerations during concurrent chemoradiotherapy for pancreatic adenocarcinoma: lessons learned from clinical experience. Am J Clin Oncol. 2013 Dec; 36(6):637-43.
    View in: PubMed
    Score: 0.006
  76. Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):298-303.
    View in: PubMed
    Score: 0.006
  77. Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. Lancet Oncol. 2013 Apr; 14(4):317-26.
    View in: PubMed
    Score: 0.006
  78. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann Surg. 1993 Feb; 217(2):149-54.
    View in: PubMed
    Score: 0.006
  79. Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase 1/2 dose escalation study. Int J Radiat Oncol Biol Phys. 2013 May 01; 86(1):96-101.
    View in: PubMed
    Score: 0.006
  80. Recent developments in radiotherapy. Curr Opin Oncol. 1992 Dec; 4(6):1099-107.
    View in: PubMed
    Score: 0.006
  81. Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 =90 U/mL and comparison to the CONKO-001 trial. Int J Radiat Oncol Biol Phys. 2012 Nov 01; 84(3):e291-7.
    View in: PubMed
    Score: 0.006
  82. A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2012 Dec 01; 84(5):1166-71.
    View in: PubMed
    Score: 0.006
  83. A simplified technique for delivering total body irradiation (TBI) with improved dose homogeneity. Med Phys. 2012 Apr; 39(4):2239-48.
    View in: PubMed
    Score: 0.006
  84. Radiation therapy for heterotopic ossification prophylaxis afer high-risk elbow surgery. Am J Orthop (Belle Mead NJ). 2011 Aug; 40(8):400-5.
    View in: PubMed
    Score: 0.005
  85. Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients. J Thorac Oncol. 2011 Jun; 6(6):1079-86.
    View in: PubMed
    Score: 0.005
  86. Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):218-24.
    View in: PubMed
    Score: 0.005
  87. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. Ann Surg Oncol. 2011 May; 18(5):1319-26.
    View in: PubMed
    Score: 0.005
  88. A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation. Ann Surg. 2011 Feb; 253(2):328-35.
    View in: PubMed
    Score: 0.005
  89. The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1328-35.
    View in: PubMed
    Score: 0.005
  90. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):985-91.
    View in: PubMed
    Score: 0.005
  91. Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial. Ann Surg Oncol. 2011 Feb; 18(2):337-44.
    View in: PubMed
    Score: 0.005
  92. Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol. 2011 Feb; 22(2):348-54.
    View in: PubMed
    Score: 0.005
  93. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer. 2010 Apr 01; 116(7):1674-80.
    View in: PubMed
    Score: 0.005
  94. Differential use of distance and location information for spatial localization. Percept Psychophys. 1990 Apr; 47(4):349-59.
    View in: PubMed
    Score: 0.005
  95. Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma. Ann Oncol. 2010 Jun; 21(6):1203-1210.
    View in: PubMed
    Score: 0.005
  96. Variation in post-surgical lumpectomy cavity volume with delay in initiation of breast irradiation because of chemotherapy. Int J Radiat Oncol Biol Phys. 2010 Jul 01; 77(3):831-5.
    View in: PubMed
    Score: 0.005
  97. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys. 2009 Jul 01; 74(3):824-30.
    View in: PubMed
    Score: 0.005
  98. Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. J Clin Oncol. 2008 Dec 20; 26(36):5918-22.
    View in: PubMed
    Score: 0.005
  99. Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer. Gastroenterology. 2009 Jan; 136(1):187-95.
    View in: PubMed
    Score: 0.005
  100. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA. 2008 Mar 05; 299(9):1019-26.
    View in: PubMed
    Score: 0.004
  101. Esthesioneuroblastoma masquerading as extramedullary plasmacytoma. Cancer. 1987 Jul 01; 60(1):88-9.
    View in: PubMed
    Score: 0.004
  102. Objective response of malignant carcinoid to radiation therapy. Int J Radiat Oncol Biol Phys. 1987 Jun; 13(6):869-73.
    View in: PubMed
    Score: 0.004
  103. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. J Clin Oncol. 1986 Oct; 4(10):1443-54.
    View in: PubMed
    Score: 0.004
  104. Phase II study of combination chemotherapy with etoposide and amsacrine in relapsed adult leukemia. Cancer Treat Rep. 1986 Apr; 70(4):535.
    View in: PubMed
    Score: 0.004
  105. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival. J Gastrointest Surg. 2005 Dec; 9(9):1191-204; discussion 1204-6.
    View in: PubMed
    Score: 0.004
  106. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study. J Clin Oncol. 2005 Aug 01; 23(22):4991-8.
    View in: PubMed
    Score: 0.004
  107. The hematopoietic toxicity of regional radiation therapy. Correlations for combined modality therapy with systemic chemotherapy. Cancer. 1985 Apr 01; 55(7):1429-35.
    View in: PubMed
    Score: 0.004
  108. A challenge to the therapeutic nihilism of ESPAC-1. Int J Radiat Oncol Biol Phys. 2005 Mar 15; 61(4):965-6.
    View in: PubMed
    Score: 0.004
  109. High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement. Biol Blood Marrow Transplant. 2005 Feb; 11(2):93-100.
    View in: PubMed
    Score: 0.003
  110. Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma. Biol Blood Marrow Transplant. 2005 Jan; 11(1):39-46.
    View in: PubMed
    Score: 0.003
  111. Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):117-25.
    View in: PubMed
    Score: 0.003
  112. Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1153-60.
    View in: PubMed
    Score: 0.003
  113. Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. Am J Clin Oncol. 2004 Feb; 27(1):51-6.
    View in: PubMed
    Score: 0.003
  114. Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria. Proc Natl Acad Sci U S A. 2003 Dec 09; 100(25):15083-8.
    View in: PubMed
    Score: 0.003
  115. Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol. 2003 Dec 15; 21(24):4553-9.
    View in: PubMed
    Score: 0.003
  116. Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10. J Clin Oncol. 2003 Sep 01; 21(17):3328-34.
    View in: PubMed
    Score: 0.003
  117. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol. 2003 Jul 01; 21(13):2519-24.
    View in: PubMed
    Score: 0.003
  118. Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610. J Clin Oncol. 2003 Apr 01; 21(7):1238-48.
    View in: PubMed
    Score: 0.003
  119. Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg. 2003 Jan; 7(1):1-9; discussion 9-11.
    View in: PubMed
    Score: 0.003
  120. Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials. Int J Radiat Oncol Biol Phys. 2003; 56(4 Suppl):31-7.
    View in: PubMed
    Score: 0.003
  121. Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. J Clin Oncol. 2001 Dec 01; 19(23):4314-21.
    View in: PubMed
    Score: 0.003
  122. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2001 Dec; 7(12):4115-21.
    View in: PubMed
    Score: 0.003
  123. Acute and late radiotherapy toxicity in patients with inflammatory bowel disease. Int J Radiat Oncol Biol Phys. 2001 Oct 01; 51(2):455-9.
    View in: PubMed
    Score: 0.003
  124. Amplification of circulating granulocyte-monocyte stem cell numbers following chemotherapy in patients with extensive small cell carcinoma of the lung. Cancer Res. 1981 Jan; 41(1):35-41.
    View in: PubMed
    Score: 0.003
  125. Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol. 2001 Jan 01; 19(1):145-56.
    View in: PubMed
    Score: 0.003
  126. Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):19-27.
    View in: PubMed
    Score: 0.003
  127. Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma. Biol Blood Marrow Transplant. 2001; 7(10):561-7.
    View in: PubMed
    Score: 0.003
  128. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival. Int J Radiat Oncol Biol Phys. 2000 Nov 01; 48(4):1089-96.
    View in: PubMed
    Score: 0.003
  129. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000 Nov-Dec; 4(6):567-79.
    View in: PubMed
    Score: 0.003
  130. Is there a role for surgical resection in the treatment of early-stage pancreatic lymphoma? J Am Coll Surg. 2000 Mar; 190(3):319-30.
    View in: PubMed
    Score: 0.002
  131. Spiral CT of colon cancer: imaging features and role in management. Radiographics. 2000 Mar-Apr; 20(2):419-30.
    View in: PubMed
    Score: 0.002
  132. Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial. Bone Marrow Transplant. 1999 Sep; 24(6):637-40.
    View in: PubMed
    Score: 0.002
  133. HIV-associated primary CNS lymorbidity and utility of brain biopsy. J Neurol Sci. 1999 Feb 01; 163(1):32-8.
    View in: PubMed
    Score: 0.002
  134. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies. Bone Marrow Transplant. 1998 Nov; 22(10):947-55.
    View in: PubMed
    Score: 0.002
  135. A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma. Hum Gene Ther. 1998 Sep 01; 9(13):1951-71.
    View in: PubMed
    Score: 0.002
  136. Should pancreaticoduodenectomy be performed in octogenarians? J Gastrointest Surg. 1998 May-Jun; 2(3):207-16.
    View in: PubMed
    Score: 0.002
  137. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am. 1997 May-Jun; 3(3):144-52.
    View in: PubMed
    Score: 0.002
  138. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg. 1997 May; 225(5):621-33; discussion 633-6.
    View in: PubMed
    Score: 0.002
  139. Pancreaticoduodenectomy and palliation in pancreatic carcinoma. Gastroenterology. 1997 Mar; 112(3):1046-8.
    View in: PubMed
    Score: 0.002
  140. Recurrent pancreatic adenocarcinoma: spiral CT evaluation following the Whipple procedure. Radiographics. 1997 Mar-Apr; 17(2):303-13.
    View in: PubMed
    Score: 0.002
  141. p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610. J Natl Cancer Inst. 1997 Jan 15; 89(2):158-65.
    View in: PubMed
    Score: 0.002
  142. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996 Oct; 224(4):463-73; discussion 473-5.
    View in: PubMed
    Score: 0.002
  143. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg. 1996 Jun; 223(6):718-25; discussion 725-8.
    View in: PubMed
    Score: 0.002
  144. Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy. Int J Radiat Oncol Biol Phys. 1996 Apr 01; 35(1):143-50.
    View in: PubMed
    Score: 0.002
  145. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol. 1996 Feb; 14(2):556-64.
    View in: PubMed
    Score: 0.002
  146. Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. Int J Radiat Oncol Biol Phys. 1995 Jun 15; 32(3):567-76.
    View in: PubMed
    Score: 0.002
  147. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg. 1995 Jun; 221(6):788-97; discussion 797-8.
    View in: PubMed
    Score: 0.002
  148. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology. 1995 Apr; 45(4):616-23.
    View in: PubMed
    Score: 0.002
  149. Breath ethane generation during clinical total body irradiation as a marker of oxygen-free-radical-mediated lipid peroxidation: a case study. Free Radic Biol Med. 1994 Dec; 17(6):569-76.
    View in: PubMed
    Score: 0.002
  150. Clinical use of on-line portal imaging for daily patient treatment verification. Int J Radiat Oncol Biol Phys. 1994 Mar 01; 28(4):1017-23.
    View in: PubMed
    Score: 0.002
  151. Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease. J Clin Oncol. 1993 Apr; 11(4):698-703.
    View in: PubMed
    Score: 0.002
  152. Ocular motor abnormalities in human immunodeficiency virus infection. Ann Neurol. 1991 Aug; 30(2):130-8.
    View in: PubMed
    Score: 0.001
  153. Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology Group. Cancer Treat Rep. 1986 Oct; 70(10):1219-20.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.